EGFR – Precision Medicine: Identifying and attacking genetic flaws | Dana-Farber Cancer Institute
1,855 views · Published 18 February 2015 · 3:01 · Indexed 30 October 2026
Channel: Dana-Farber Cancer Institute · 2015 · Science & Technology
What if we could treat cancer by going after the genes responsible for the disease? Dana-Farber discovered that lung cancer patients with the EGFR mutation responded dramatically to targeted therapies. The findings helped launch the era of precision medicine for lung cancer. Learn more about our discoveries at http://www.DiscoverCareBelieve.org.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute